TY - JOUR
T1 - Bicondylar Tibial Plateau Fractures
T2 - What Predicts Infection?
AU - Olszewski, Nathan
AU - Manzano, Givenchy
AU - Wilson, Eleanor
AU - Joseph, Noah
AU - Vallier, Heather
AU - Pawlak, Amanda
AU - Kottmeier, Stephen
AU - Miller, Adam
AU - Gary, Joshua
AU - Namm, Joshua
AU - Miller, Anna
AU - Gupte, Guarang
AU - Rodriguez-Buitrago, Andre
AU - Obremskey, William
AU - Willier, Donald
AU - Marcantonio, Andrew
AU - Phieffer, Laura
AU - Sheridan, Elizabeth
AU - Li, Katerine
AU - Karunakar, Madhav
AU - Vargas-Hernandez, Juan
AU - Yuan, Brandon
AU - Shapiro, Joshua
AU - Pratson, Lincoln
AU - Friess, Darin
AU - Jenkins, David
AU - Leighton, Ross
AU - Alqudhaya, Rashed
AU - Aljilani, Waael
AU - Mullis, Brian
AU - Gruenwald, Konstantin
AU - Ollivere, Benjamin
AU - Myint, Yulanda
AU - Odom, Christopher
AU - Spitler, Clay
AU - Suwak, Patrik
AU - Shah, Sagar
AU - Rocha, Daniela
AU - Horwitz, Daniel
AU - Tornetta, Paul
N1 - Funding Information:
Olszewski or an immediate family member serves on committees for the AAOS and OTA. Tornetta III or an immediate family member serves on the editorial or governing board for the Journal of Orthopaedic Trauma; has intellectual property with Smith & Nephew; and has publishing agreement with Wolters Kluwer. Vallier or an immediate family member serves as a board or committee member for the OTA and serves on the editorial or governing board for JOT. Kottmeier or an immediate family member serves as a board or committee member for the AAOS and OTA and serves an editor or on the governing board for Wolters Kluwer. Gary or an immediate family member is a paid presenter or speaker for Stryker, Smith & Nephew, and Synthes; has stock or stock options in Summit Medventures; serves as a board or committee member for the OTA and AO North America; and serves on the editorial or governing board of JBJS-American and JAAOS. Adam Miller or an immediate family member receives funding from Smith & Nephew, Stryker, AONA, and Bonesupport; serves as a board or committee member for the OTA, ACS, and Association for the advancement of Automotive Medicine; and serves on the editorial or governing board of JBJS-American and JOT. Marcantonio or an immediate family member serves as a board or committee member for NEOS and receives financial support from AOTrauma North America. Obremskey or an immediate family member serves as a committee or board member for the Southeastern Fracture Consortium and serves on the editorial or governing board for JBJS, JOT, and JAAOS. Phieffer or an immediate family member serves as a paid consultant for Johnson & Johnson. Karunakar or an immediate family member serves as an unpaid consultant for OsteoCentric; serves as a paid consultant for Synthes; serves as a board or committee member for the OTA; and serves on the editorial or governing board for JOT. Leighton or an immediate family member is a paid speaker for Synthes, Zimmer, and Stryker; serves as a paid consultant for Etex; receives financial support from Smith & Nephew and DePuy; and serves as a board or committee member for the AAOS and Canadian Orthopaedic Association. Mullis or an immediate family member serves as a paid consultant for KCI and serves as a board or committee member for the AO Research Committee, the Indiana Orthopaedic Society, and the OTA. Ollivere or an immediate family member has received royalties from Smith & Nephew; serves as a paid consultant for Medartis, Xirios, and Zimmer; serves as a board member of the AO UK; and serves on the editorial and governing board for the JBJS-British. Spitler or an immediate family member is a paid speaker for AO Trauma; serves as a paid consultant for DePuy and KCI; has stock options held in ROM 3 Rehab; serves as a committee or board member for the AAOS; and serves on the editorial or governing board for the JBJS-American. Horwitz or an immediate family member receives royalties from NewClip & Biomet; serves as a paid consultant for DePuy and Biomet; has received research support from Synthes; serves as a board or committee member for the OTA, FOT, and AAOS; and serves on the editorial or governing board for Wolters Kluwer Health. None of the following authors or any immediate family member has received anything of value from or has stock or stock options held in a commercial company or institution related directly or indirectly to the subject of this article: Manzano, Wilson, Joseph, Pawlak, Adam Miller, Gupte, Rodriguez-Buitrago, Obremskey, Willier, Sheridan, Li, Vargas-Hernandez, Yuan, Shapiro, Pratson, Friess, Jenkins, Alqudhaya, Aljilani, Gruenwald, Myint, Odom, Suwak, Shah, and Rocha.
Publisher Copyright:
© American Academy of Orthopaedic Surgeons.
PY - 2022/10/15
Y1 - 2022/10/15
N2 - Objectives:The purpose of this study was to identify the patient, injury, and treatment factors associated with infection of bicondylar plateau fractures and to evaluate whether center variation exists.Design:Retrospective review.Setting:Eighteen academic trauma centers.Patients/participants:A total of 1,287 patients with 1,297 OTA type 41-C bicondylar tibia plateau fractures who underwent open reduction and internal fixation were included. Exclusion criteria were follow-up less than 120 days, insufficient documentation, and definitive treatment only with external fixation.Intervention:Open reduction and internal fixation.Main outcome measurements:Superficial and deep infection.Results:One hundred one patients (7.8%) developed an infection. In multivariate regression analysis, diabetes (DM) (OR [odds ratio] 3.24; P ≤ 0.001), alcohol abuse (EtOH) (OR 1.8; P = 0.040), dual plating (OR 1.8; P ≤ 0.001), and temporary external fixation (OR 2.07; P = 0.013) were associated with infection. In a risk-adjusted model, we found center variation in infection rates (P = 0.030).Discussion:In a large series of patients undergoing open reduction and internal fixation of bicondylar plateau fractures, the infection rate was 7.8%. Infection was associated with DM, EtOH, combined dual plating, and temporary external fixation. Center expertise may also play a role because one center had a statistically lower rate and two trended toward higher rates after adjusting for confounders.Level of evidence:Level IV - Therapeutic retrospective cohort study.
AB - Objectives:The purpose of this study was to identify the patient, injury, and treatment factors associated with infection of bicondylar plateau fractures and to evaluate whether center variation exists.Design:Retrospective review.Setting:Eighteen academic trauma centers.Patients/participants:A total of 1,287 patients with 1,297 OTA type 41-C bicondylar tibia plateau fractures who underwent open reduction and internal fixation were included. Exclusion criteria were follow-up less than 120 days, insufficient documentation, and definitive treatment only with external fixation.Intervention:Open reduction and internal fixation.Main outcome measurements:Superficial and deep infection.Results:One hundred one patients (7.8%) developed an infection. In multivariate regression analysis, diabetes (DM) (OR [odds ratio] 3.24; P ≤ 0.001), alcohol abuse (EtOH) (OR 1.8; P = 0.040), dual plating (OR 1.8; P ≤ 0.001), and temporary external fixation (OR 2.07; P = 0.013) were associated with infection. In a risk-adjusted model, we found center variation in infection rates (P = 0.030).Discussion:In a large series of patients undergoing open reduction and internal fixation of bicondylar plateau fractures, the infection rate was 7.8%. Infection was associated with DM, EtOH, combined dual plating, and temporary external fixation. Center expertise may also play a role because one center had a statistically lower rate and two trended toward higher rates after adjusting for confounders.Level of evidence:Level IV - Therapeutic retrospective cohort study.
UR - http://www.scopus.com/inward/record.url?scp=85139377242&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139377242&partnerID=8YFLogxK
U2 - 10.5435/JAAOS-D-21-00432
DO - 10.5435/JAAOS-D-21-00432
M3 - Article
C2 - 36200819
AN - SCOPUS:85139377242
SN - 1067-151X
VL - 30
SP - E1311-E1318
JO - Journal of the American Academy of Orthopaedic Surgeons
JF - Journal of the American Academy of Orthopaedic Surgeons
IS - 20
ER -